Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study
Adrienne Chan, Tiantian Ma, Wallis C. Y. Lau, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101780-101780
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Evaluating ADHD medication trial representativeness: a Swedish population-based study comparing hypothetically trial-eligible and trial-ineligible individuals
Miguel Garcia‐Argibay, Zheng Chang, Isabell Brikell, et al.
The Lancet Psychiatry (2025)
Closed Access | Times Cited: 2
Online interest in ADHD predicts ADHD medication prescriptions in Australia from 2004 to 2023: A time-series analysis revealing COVID-19-related acceleration
Luke Sy‐Cherng Woon, David Smith, Stephen Allison, et al.
Australasian Psychiatry (2025)
Closed Access | Times Cited: 1
ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases
Isabell Brikell, Honghui Yao, Lin Li, et al.
The Lancet Psychiatry (2023) Vol. 11, Iss. 1, pp. 16-26
Open Access | Times Cited: 19
Psychopharmacology in children and adolescents: unmet needs and opportunities
Samuele Cortese, Diane Purper‐Ouakil, Alan Apter, et al.
The Lancet Psychiatry (2023) Vol. 11, Iss. 2, pp. 143-154
Open Access | Times Cited: 14
Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use
Tobias Banaschewski, Alexander Häge, Sarah Hohmann, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 4
La prescription de médicaments psychotropes chez l’enfant et l’adolescent en France : caractéristiques et évolution entre 2010 et 2023
Sébastien Ponnou, Xavier Briffault, Victor Aragno, et al.
Neuropsychiatrie de l Enfance et de l Adolescence (2025)
Open Access
Antipsychotic Drug Prescribing in Children Previously Treated With Stimulants for ADHD: A Population-Based Longitudinal Study: La prescription d'antipsychotiques chez les enfants précédemment traités avec des stimulants pour le TDAH : une étude longitudinale basée sur la population
Hans J. Gober, Kathy H. Li, Bruce Carleton
The Canadian Journal of Psychiatry (2025)
Closed Access
Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study
Blair Aitken, Luke A. Downey, Serah Rose, et al.
Human Psychopharmacology Clinical and Experimental (2025) Vol. 40, Iss. 2
Open Access
EnvironMental Health: A Framework for an Emerging Field at the Intersection of the Environment and Mental Health Crises
Lars Ratjen, E. D. Goddard, Elise B. Gilcher, et al.
GeoHealth (2025) Vol. 9, Iss. 2
Open Access
The Use of Novel Stimulants in ADHD Self-Medication: A Mixed Methods Analysis
Tayler Holborn, Fabrizio Schifano, Emma Smith, et al.
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 292-292
Open Access
Socioeconomic status and prescribing of ADHD medications: a study of ICB-level data in England
Muhammad Umair Khan, Syed Shahzad Hasan
BMJ Mental Health (2025) Vol. 28, Iss. 1, pp. e301384-e301384
Open Access
Test of Gross Motor Development 2 (TGMD-2) for Motor Skills in ADHD with Speech Delay
Ahmad Syahru Mubarok Harisman, Lokananta Teguh Hari Wiguno, Herdhika Ayu Retno Kusumasari, et al.
KnE Social Sciences (2025) Vol. 10, Iss. 7, pp. 90-102
Open Access
Prevalence and Incidence of Attention Deficit/Hyperactivity Disorder in Denmark. A National Register‐Based Open Cohort Study
Simon Grøntved, Kathrine Hald, Christina Mohr Jensen, et al.
Acta Psychiatrica Scandinavica (2025)
Open Access
WHO Model Lists of Essential Medicines: methylphenidate for ADHD in children and adolescents
Samuele Cortese, David Coghill, Gregory W. Mattingly, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 10, pp. 743-744
Closed Access | Times Cited: 9
Methylphenidate and Sleep Difficulties in Children and Adolescents With ADHD: Results From the 2-Year Naturalistic Pharmacovigilance ADDUCE Study
Alexander Häge, Kenneth K. C. Man, Sarah K. Inglis, et al.
Journal of Attention Disorders (2024) Vol. 28, Iss. 5, pp. 699-707
Open Access | Times Cited: 3
Optimal exercise intensity for improving executive function in patients with attention deficit hyperactivity disorder: systematic review and network meta-analysis
Ji-Wei Chen, Wen-Qian Du, Kun Zhu
European Child & Adolescent Psychiatry (2024)
Closed Access | Times Cited: 3
Changes in parental attitudes toward attention‐deficit/hyperactivity disorder impairment over time
Miguel Garcia‐Argibay, Ralf Kuja‐Halkola, Sebastian Lundström, et al.
JCPP Advances (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 2
Recent trends in psychotropic medication use in children and adolescents in Ireland
Rebecca Parkin, Kathleen Bennett, Fiona Mc Nicholas, et al.
European Child & Adolescent Psychiatry (2024)
Open Access | Times Cited: 2
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review
Stefania Chiappini, Pietro Domenico Gramuglia, Alessio Mosca, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Attention deficit/Hyperactivity disorder
Kevin M. Antshel, Haley McBride
Elsevier eBooks (2023), pp. 63-77
Closed Access | Times Cited: 6
Single Exercise for Core Symptoms and Executive Functions in ADHD: A Systematic Review and Meta-Analysis
Ji-Wei Chen, Kun Zhu
Journal of Attention Disorders (2023) Vol. 28, Iss. 4, pp. 399-414
Closed Access | Times Cited: 5
Absence of funding for pharmacotherapy for adults with ADHD in Poland
Daniel Pankowski, Kinga Wytrychiewicz-Pankowska
The Lancet Psychiatry (2024) Vol. 11, Iss. 6, pp. 410-411
Open Access | Times Cited: 1
Dynamic functional connectivity analysis with temporal convolutional network for attention deficit/hyperactivity disorder identification
Mingliang Wang, Lingyao Zhu, Xizhi Li, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 3
Prevalence and Clinical Profile of Adults with ADHD Attending a Tertiary Care Hospital for Five Years
Rabab Mohammed Bedawi, Yahya Al‐Farsi, Hassan Mirza, et al.
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 5, pp. 566-566
Open Access
A gyermekkori figyelemzavar és hiperaktivitás kezelése a magyar közfinanszírozott ellátásban
Péter Nagy, Gábor Bársony, Róbert Frigyesy, et al.
IME - Az egészségügyi vezetők szaklapja (2024) Vol. 23, Iss. 2., pp. 49-58
Open Access
Page 1 - Next Page

Scroll to top